Article
RheumNow Live (RNL) for 2021 was held March 20 - 21 in Fort Worth, TX, and now all can partake in the meeting - by video, podcast or by signing up for Tuesday Nite Rheumatology (TNR).
All News
Article
Sparks and colleagues have published a matched cohort analysis demonstrating risk factors that may augment the risk of rheumatoid arthritis (RA)-associated interstitial lung disease (ILD), especially the combination of obesity, high CRP, high MD-HAQ and >30 pack-year smoking h
Article
NSAIDs do not affect COVID outcomes; here we are nearly 16 months into the pandemic, and this is the common sense conclusion of a recent trial published in Lancet Rheumatology.
Article
Dr. Jack Cush reviews the best journal articles from the past week on RheumNow.com.
Article
An oral microbiome study of rheumatoid arthritis patients suggests that periodontal condition in patients with early rheumatoid arthritis and individuals at risk of RA.
Article
The ARTIC-REWIND study examined rheumatoid arthritis (RA) patients in remission on conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) to see if they could "step-down" their csDMARDs theray; but the study showed that 25% those who went on half-dose experienced disease fl
Article
The predictive value of therapeutic drug monitoring (TDM) while on biologics is debateable; gastroenterology routinely relies on TDM, while rheumatologists do not.
Article
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.
Article
A metanalysis showed that while adverse events (AEs) are common when methotrexate is used in rheumatoid arthritis or inflammatory arthritis patients, serious AEs ranged from 2.1 to 9.5% and drug discontinuations ranged from 6.7% to 15.5%, mostly due to gastrointestinal events.
Article
Dr. Jack Cush reviews and discusses more than a dozen news and journal articles from the past week on RheumNow.com.
Dr. John Cush
Tweet
Cerecor has launched a c Phase 1b clinical trial (NCT04752371) of the human mAb CERC-007, targeting IL-18, in 12 patients with active adult onset Still’s disease (AOSD). They estimate AOSD affects 3,500 - 7,000 in the US 3,400 - 6,900 pts in Europe https://t.co/DlW1QbXOG0
Dr. John Cush
Tweet
News Feature: Risk Factors for Rheumatoid Arthritis-associated Interstitial Lung Disease
https://t.co/ps8JeRUtJf https://t.co/Sn6ykG9ZuE
Dr. John Cush
Tweet
Sulfasalazine may be in short supply. FDA shortage lists shortage with drug return in July or 4th quarter of 2021. ASHP site also notes several generic maker shortages but they suggest resolution mid-May or July https://t.co/XYyraO6Z4z https://t.co/tm50S7ov9K https://t.co/QPWIitYkpp
Dr. John Cush
Tweet
Systematic review of the epidemiology of #RA shows average point and period prevalence of RA to be 51 to 56 per 10,000, respectively. Higher with rheumatologist diagnosis (81 per 10,000). https://t.co/5AeNdmBLJO
Dr. John Cush
Tweet
News Feature: Unique Oral Microbiome in Early and Pre-Clinical RA
An oral microbiome study of rheumatoid arthritis (RA) patients suggests that periodontal condition in patients with early rheumatoid arthritis (ERA) and individuals at risk of RA.
https://t.co/r3kT52MByC https://t.co/MocZ6PXZzA
Dr. John Cush
Tweet
New podcast alert!
Falling or Falling in Love (5.7.2021)
Dr Jack Cush reviews the best journal articles of the week from RheumNow
https://t.co/HyAPN2rM3L https://t.co/C5XtqthO8I
Dr. John Cush
Tweet
Falls are not uncommon in #RA patients; significant risk factors for falls include being elderly, un-married, higher pain scores, reported dizziness taking psychotropic medications and having lower HRQoL scores https://t.co/a8qA7n68q5
Dr. John Cush
Tweet
New download available! Osteoarthritis vs. Rheumatoid Arthritis
https://t.co/qvVEcKqNAM https://t.co/3f8sRSgyQo
Dr. John Cush
Tweet
Real world comparision of baricitinib (n 138) and tofacitinib (n 156) in #RA patients shows at wk 24, BARI out performed TOFA - CDAI remission (40.4 vs 28.3%) and CDAI LDA (81.6 vs 69.3%); safety signals were equal between groups. https://t.co/0quNNGB18K
Dr. John Cush
Tweet
Coconspirators: RA and Lung Disease
Download this week's RheumNow podcast, where Dr. Cush reviews the news and journal articles for the last week.
https://t.co/MJbfJANWwt https://t.co/PUqewOvBjZ
